Cargando…
A Case of Allergic Bronchopulmonary Aspergillosis With Failure of Benralizumab and Response to Dupilumab
We report a case of a 68-year-old woman who was being treated for bronchial asthma and developed allergic bronchopulmonary aspergillosis (ABPA) that was unresponsive to benralizumab therapy but went into remission with dupilumab therapy. The patient presented with an exacerbation of dry cough and wa...
Autores principales: | Kotetsu, Yasuaki, Ogata, Hiroaki, Sha, Kachi, Moriwaki, Atsushi, Yoshida, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450248/ https://www.ncbi.nlm.nih.gov/pubmed/37637670 http://dx.doi.org/10.7759/cureus.42464 |
Ejemplares similares
-
Tezepelumab treatment for allergic bronchopulmonary aspergillosis
por: Ogata, Hiroaki, et al.
Publicado: (2023) -
A Case of Allergic Bronchopulmonary Aspergillosis With Bronchial Asthma
por: Rajpopat, Pratik Bharat, et al.
Publicado: (2022) -
Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab
por: Mikura, Sunao, et al.
Publicado: (2021) -
Allergic Bronchopulmonary Aspergillosis in a Patient With Poorly Controlled Bronchial Asthma
por: Gamalathge, Dimithra R, et al.
Publicado: (2023) -
Duration of Intensive Respiratory Support and Risk of Long-term Respiratory Failure in Patients with COVID-19
por: Ogata, Hiroaki, et al.
Publicado: (2022)